Biologic importance of neuraminidase stalk length in influenza A virus

To investigate the biologic importance of the neuraminidase (NA) stalk of influenza A virus, we generated mutant viruses of A/WSN/33 (H1N1) with stalks of various lengths (0 to 52 amino acids), by using the recently developed reverse genetics system. These mutant viruses, including one that lacked the entire stalk, replicated in tissue culture to the level of the parent virus, whose NA stalk contains 24 amino acid residues. In eggs, however, the length of the stalk was correlated with the efficiency of virus replication: the longer the stalk, the better the replication. This finding indicates that the length of the NA stalk affects the host range of influenza A viruses. The NA stalkless mutant was highly attenuated in mice; none of the animals died even after intranasal inoculation of 10(6) PFU of the virus (the dose of the parent virus required to kill 50% of mice was 10(2.5) PFU). Moreover, the stalkless mutant replicated only in the respiratory organs, whereas the parent virus caused systemic infection in mice. Thus, attenuation of the virus with the deletion of the entire NA stalk raises the possibility of its use as live vaccines.

[1]  R. Compans,et al.  Characterization of temperature sensitive influenza virus mutants defective in neuraminidase. , 1974, Virology.

[2]  J. Parvin,et al.  Amplification, expression, and packaging of a foreign gene by influenza virus , 1989, Cell.

[3]  P. Palese,et al.  Introduction of site-specific mutations into the genome of influenza virus. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[4]  G. Brownlee,et al.  The sequence of the nucleoprotein gene of human influenza A virus, strain A/NT/60/68. , 1982, Nucleic acids research.

[5]  K. Mullis,et al.  Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. , 1988, Science.

[6]  B. Murphy,et al.  An influenza A virus containing influenza B virus 5' and 3' noncoding regions on the neuraminidase gene is attenuated in mice. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[7]  Y. Kawaoka,et al.  Attenuation of influenza A virus by insertion of a foreign epitope into the neuraminidase , 1992, Journal of virology.

[8]  W G Laver,et al.  An 18-amino acid deletion in an influenza neuraminidase. , 1985, Virology.

[9]  Molecular cloning and analysis of the N5 neuraminidase subtype from an avian influenza virus. , 1989, Virology.

[10]  J. Almond.  The attenuation of poliovirus neurovirulence. , 1987, Annual review of microbiology.

[11]  W. J. Bean,et al.  Intestinal influenza: Replication and characterization of influenza viruses in ducks , 1978, Virology.

[12]  W. G. Laver,et al.  Crystallization and peptide maps of neuraminidase "heads" from H2N2 and H3N2 influenza virus strains. , 1978, Virology.

[13]  W. J. Bean,et al.  Biologic potential of amantadine-resistant influenza A virus in an avian model. , 1989, The Journal of infectious diseases.

[14]  C. Bona,et al.  Influenza A virus transfectants with chimeric hemagglutinins containing epitopes from different subtypes , 1992, Journal of virology.

[15]  M. Ueda,et al.  Neurovirulence of influenza virus in mice. I. Neurovirulence of recombinants between virulent and avirulent virus strains. , 1980, Virology.

[16]  J. Parvin,et al.  Promoter analysis of influenza virus RNA polymerase , 1989, Journal of virology.

[17]  T. Kunkel.  Rapid and efficient site-specific mutagenesis without phenotypic selection. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[18]  C. Naeve,et al.  Identification of sequence changes in the cold-adapted, live attenuated influenza vaccine strain, A/Ann Arbor/6/60 (H2N2). , 1988, Virology.

[19]  J. N. Varghese,et al.  Structure of the influenza virus glycoprotein antigen neuraminidase at 2.9 Å resolution , 1983, Nature.

[20]  G. Wertz,et al.  Replication and amplification of defective interfering particle RNAs of vesicular stomatitis virus in cells expressing viral proteins from vectors containing cloned cDNAs , 1990, Journal of virology.

[21]  R. Webster,et al.  Changes in the antigenicity of the hemagglutinin molecule of H3 influenza virus at acidic pH. , 1983, Virology.

[22]  B. Murphy,et al.  The A/Mallard/6750/78 avian-human, but not the A/Ann Arbor/6/60 cold-adapted, influenza A/Kawasaki/86 (H1N1) reassortant virus vaccine retains partial virulence for infants and children. , 1991, The Journal of infectious diseases.

[23]  P. Palese,et al.  High-efficiency formation of influenza virus transfectants , 1991, Journal of virology.

[24]  W G Laver,et al.  Molecular mechanisms of variation in influenza viruses , 1982, Nature.

[25]  G. Air,et al.  The neuraminidase of influenza virus , 1989, Proteins.

[26]  P. Collins,et al.  Rescue of synthetic analogs of respiratory syncytial virus genomic RNA and effect of truncations and mutations on the expression of a foreign reporter gene. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[27]  M. Hilleman.  Antigenic variation of influenza viruses. , 1954, Annual review of microbiology.

[28]  B. Murphy,et al.  Comparison of live, attenuated H1N1 and H3N2 cold-adapted and avian-human influenza A reassortant viruses and inactivated virus vaccine in adults. , 1988, The Journal of infectious diseases.

[29]  B. Murphy,et al.  Comparison of live attenuated cold-adapted and avian-human influenza A/Bethesda/85 (H3N2) reassortant virus vaccines in infants and children. , 1990, The Journal of infectious diseases.

[30]  C. Benham,et al.  An influenza virus containing nine different RNA segments. , 1991, Virology.

[31]  F. F. Correia,et al.  Rescue of a foreign gene by Sendai virus. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[32]  G. Air.  Nucleotide sequence coding for the "signal peptide" and N terminus of the hemagglutinin from an asian (H2N2) strain of influenza virus. , 1979, Virology.

[33]  B. Murphy,et al.  ADVANTAGE OF LIVE ATTENUATED COLD-ADAPTED INFLUENZA A VIRUS OVER INACTIVATED VACCINE FOR A/WASHINGTON/80 (H3N2) WILD-TYPE VIRUS INFECTION , 1984, The Lancet.